www.verygoodnewsisrael.blogspot.com
Israeli innovations just get more and more exciting. The week that Israel began human trials of its Covid-19 vaccine, saw several other groundbreaking achievements. They include a new generation of antibiotics, new treatments for eye disease and diabetes, discovery of how the brain learns movement, detecting heart attacks from speech and new fast tests for Covid-19 infections. Israel sent humanitarian aid to Europe and Asia. There were scientific breakthroughs in robotics, X-ray generation, recycling and accident prevention. Economic breakthroughs continue with the UAE, India, Japan, Italy and global maritime transportation. Israel21c has launched “Groundbreaking Israel” and groundbreaking projects are underway in Israel’s capital.
ISRAEL’S MEDICAL ACHIEVEMENTS
First human tests of Israeli Covid-19 vaccine. On Nov 1, two Israelis received the first doses of Israel’s coronavirus vaccine candidate developed by the Israel Institute of Biological Research. The volunteers were inoculated at Sheba Medical Center in Tel Hashomer and Hadassah’s Jerusalem Ein Kerem Medical Center.
https://www.timesofisrael.com/first-2-volunteers-injected-with-israeli-virus-vaccine-kicking-off-human-trials/
https://www.jpost.com/health-science/israel-launches-coronavirus-vaccine-human-trials-647631
https://www.youtube.com/watch?v=JJiEVoP-Hs8
The next generation of antibiotics. Israel’s Omnix Medical (reported here previously( is developing novel antibiotic agents for the treatment of hospital-acquired infections involving resistant bacteria. Omnix has successfully completed lab testing and has now raised funding to allow it to commence human clinical trials.
https://www.calcalistech.com/ctech/articles/0,7340,L-3868294,00.html https://www.omnixmedical.com/
How the brain learns movement. Scientists at Israel’s Technion Institute have discovered which of the brain’s neurons are involved in learning complex movements of the body. These neurons remember success or failure and adjust their initial state for the next trial, so that the body’s movement can adapt.
https://www.technion.ac.il/en/2020/10/skilled-movement-the-brain/
Monitoring high blood pressure in the voice. Israel’s Vocalis (reported here previously) has partnered with the Mayo Clinic to detect and monitor pulmonary hypertension (PH) from analyzing a person’s voice. Initially, they will identify PH vocal biomarkers indicating an increase in blood pressure within the arteries of the lungs.
https://www.timesofisrael.com/israels-vocalis-mayo-clinic-to-develop-voice-based-medical-biomarkers/
New microcatheter saves patient. Doctors at Israel’s Sheba Neuro-Interventional & Stroke Center performed a unique procedure using the BENDIT steerable microcatheter. They saved a 74-year-old Israeli who had a giant brain aneurysm that was compressing his brainstem and had a high risk of brain hemorrhage.
https://www.israelhayom.com/2020/10/30/man-survives-brain-aneurysm-thanks-to-israeli-startups-device/
https://www.bendittech.com/
Joint Israeli-UAE stem cells project. (TY Atid-EDI) Israel’s Pluristem (reported here previously) and the Abu Dhabi Stem Cells Center (ADSCC) have unveiled their first joint projects. One – a potential Covid-19 treatment – is the first time Pluristem’s PLX cells will have been administered via a nebulizer.
https://www.globenewswire.com/news-release/2020/10/01/2101896/0/en/Abu-Dhabi-Stem-Cells-Center-and-Pluristem-Unveil-Joint-Projects-at-Malta-Conferences-Foundation-Online-Event.html
Diabetes treatment in US. (TY Atid-EDI) Israel’s DreaMed Diabetes (see here) has partnered a number of US health clinics. Lucile Packard Children’s Hospital Stanford; Billings Clinic Montana; Hassenfeld Children’s Hospital, NYU Langone and UF Health will provide diabetes patients with DreaMed’s personalized solutions.
https://www.businesswire.com/news/home/20200930005419/en/DreaMed-Expands-Its-Remote-Diabetes-Solution-to-Four-Clinics-Across-The-U.S.
Knee cartilage implant is a breakthrough. (TY Atid-EDI) Israel’s CartiHeal (reported here previously) has received US FDA breakthrough device designation for its Agili-C implant. Agili-C has been implanted in over 500 study patients with knee, ankle and big toe cartilage lesions in trials at leading centers in Europe and Israel.
https://www.prnewswire.com/il/news-releases/cartiheal-receives-fda-breakthrough-device-designation-for-the-novel-agili-c-implant-301150023.html